Diagnosing MonoMAC Syndrome in GATA2 Germline Mutated Myelodysplastic Syndrome via Next-Generation Sequencing in a Patient with Refractory and Complex Infection: Case Report and Literature Review

Infect Drug Resist. 2021 Apr 6:14:1311-1317. doi: 10.2147/IDR.S305825. eCollection 2021.

Abstract

Monocytopenia and mycobacterial infection (MonoMAC) syndrome is a rare disease. Herein, we reported a 65-year-old Asian woman, previously diagnosed with myelodysplastic syndrome (MDS), suffering from recurrent pneumonia, intermittent fever, fatigue, and chest tightness lasting for five months. She was ultimately diagnosed with MonoMAC syndrome with Mycobacterium kansasii (M. kansasii) infection and GATA2 mutation through metagenomic generation sequencing (mNGS) of peripheral blood specimen, for which she was given anti-NTM therapy. Her situation significantly improved within 2 weeks of therapy. We discussed the clinical features, genetic characteristic, and prognosis of this disorder, aiming to further elucidate this rare syndrome. For MDS/AML patient with recurrent mixed infection and pancytopenia (especially with monocyte absence), MonoMAC syndrome should be highly suspected, and germline mutation and pathogen sequencing should be performed.

Keywords: GATA-2 germline mutation; M. kansasii; MonoMAC; monocytopenia and mycobacterial infection syndrome; next-generation sequencing; nontuberculous mycobacteria.

Publication types

  • Case Reports

Grants and funding

This study was supported by National Natural Science Foundation of China (NO. 81603573), Zhejiang Traditional Chinese Medicine Scientific Research Foundation (NO. 2020ZB085) and Science and Technology Department of Zhejiang Research Foundation (NO.2019C03047).